Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02914899 · ClinicalTrials.gov registry record · Early Phase 1
Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community
A Early Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 99
- Enrollment target
NCT02914899: Completed Early Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02914899 is a Early Phase 1 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 99 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (87% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02914899, a Early Phase 1 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 99 participants
- Enrollment target
Study Summary
The purpose of this study is to test if our Community Health Worker program can help at-risk NYC Chinese community members participate in shared decision making and lung cancer screening (if appropriate) and compare it to the help provided by written materials.
Primary Outcome
To determine whether participation in the interventions leads to increased completion of SDM and LCS with LDCT.
Interventions
- BEHAVIORAL Navigation
- BEHAVIORAL Surveys
- BEHAVIORAL Focus groups
- BEHAVIORAL In-depth interviews
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2016-08-01 |
| Est. Completion | 2025-11-19 |
| Phase | Early Phase 1 |
What the finished NCT02914899 record still lists
NCT02914899 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (87% higher).
The record links to 0 conditions, and to 4 interventions - of which Navigation is the first listed.
NCT02914899 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02914899 about?
NCT02914899 is a clinical study titled "Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community". The purpose of this study is to test if our Community Health Worker program can help at-risk NYC Chinese community members participate in shared decision making and lung cancer screening (if appropriate) and compare it to the help provided by written materials.
What is the current status of trial NCT02914899?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 99 participants. The study started on 2016-08-01. Estimated completion is 2025-11-19.
What interventions are being tested in trial NCT02914899?
The interventions under investigation include: Navigation (BEHAVIORAL), Surveys (BEHAVIORAL), Focus groups (BEHAVIORAL), In-depth interviews (BEHAVIORAL).
Who is sponsoring clinical trial NCT02914899?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02914899's enrollment target sits among peer trials
99 219th of 2000 higher than 1,781 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI